tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports

Tenaya Therapeutics (TNYA) Stock News & Sentiment

3,119 Followers
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
Premium
Ratings
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
1M ago
TNYA
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
Premium
Ratings
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
1M ago
TNYA
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
Premium
Ratings
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
1M ago
TNYA
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
1M ago
EVAX
IMRX
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
Premium
Ratings
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
1M ago
TNYA
Tenaya Therapeutics: Alnylam Partnership Validates Cardiovascular Platform and Supports Long-Term Buy Thesis
Premium
Ratings
Tenaya Therapeutics: Alnylam Partnership Validates Cardiovascular Platform and Supports Long-Term Buy Thesis
1M ago
TNYA
Tenaya Therapeutics: Alnylam Collaboration De-Risks Platform and Expands Cardiovascular Upside, Supporting Buy Rating
Premium
Ratings
Tenaya Therapeutics: Alnylam Collaboration De-Risks Platform and Expands Cardiovascular Upside, Supporting Buy Rating
1M ago
TNYA
More TNYA News >

TNYA News on the Web

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sagimet Biosciences, Inc. Class A (SGMT)
TipRanks News
Bullish
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
TipRanks News
Bullish
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
TipRanks News
Bullish
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
TipRanks News
Bullish
Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)
TipRanks News
Bullish
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
TipRanks News
Bullish
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
TipRanks News
Bullish
Tenaya Therapeutics presents preclinical data evaluating TN-301
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TNYA’s Media Buzz Sentiment?
Currently, no data Available
What is TNYA’s weekly average amount of articles?
Currently, no data Available
What is TNYA’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week